University Researchers are Currently Measuring COVID-19 Antibodies in Maltese Population
A University of Malta study measuring the antibodies generated by COVID-19 patients has just secured €658,972 in funding through the Malta Council for Science and Technology (MCST) and Malta Enterprise (ME).
Results from the Cov-Plex study, which will span over the next 12 months, will be vital for vaccine surveillance in the Maltese population, as it will generate knowledge towards the understanding of the efficacy of the available vaccines while better understanding the immune response being developed by the population.
Prof. Godfrey Grech, a member of the Department of Pathology within the Faculty of Medicine and Surgery, will be leading the study alongside Prof. Christian Scerri from the Department of Physiology & Biochemistry within the same Faculty.